Synovial tissue analysis in clinical trials.
Barry Bresnihan(St. Vincent's University Hospital), Paul P. Tak(Celldex Therapeutics (United States)), Daniëlle M. Gerlag(UCB Pharma (United Kingdom)), Gary S. Firestein(Inflammation Research Foundation), Douglas J. Veale(St. Vincent's University Hospital), Ann-Kristin Ulfgren, Dominique Baeten(University of Amsterdam), Iain B. McInnes(University of Glasgow), Oliver FitzGerald(University College Dublin), Jasper J. Haringman(Isala), Malcolm Smith(Repatriation General Hospital), Richard J. Reece
PubMed
December 1, 2005
Cited by 28
Related Papers
NF-κB: a key role in inflammatory diseases
|Journal of Clinical Investigation|2001|3.9k
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
|Pharmacology & Therapeutics|2007|1.6k
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
|Nature Immunology|2019|1.4k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k